These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunopathological effects of malaria pigment or hemozoin and other crystals. Tyberghein A; Deroost K; Schwarzer E; Arese P; Van den Steen PE Biofactors; 2014; 40(1):59-78. PubMed ID: 23907956 [TBL] [Abstract][Full Text] [Related]
5. Immune evasion by malaria parasites: a challenge for vaccine development. Casares S; Richie TL Curr Opin Immunol; 2009 Jun; 21(3):321-30. PubMed ID: 19493666 [TBL] [Abstract][Full Text] [Related]
6. Innate inflammatory response to the malarial pigment hemozoin. Shio MT; Kassa FA; Bellemare MJ; Olivier M Microbes Infect; 2010 Nov; 12(12-13):889-99. PubMed ID: 20637890 [TBL] [Abstract][Full Text] [Related]
7. Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design. Taylor-Robinson AW Exp Parasitol; 2010 Nov; 126(3):406-14. PubMed ID: 20138874 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors. Nebl T; De Veer MJ; Schofield L Parasitology; 2005; 130 Suppl():S45-62. PubMed ID: 16281992 [TBL] [Abstract][Full Text] [Related]
9. Hemozoin in Malarial Complications: More Questions Than Answers. Pham TT; Lamb TJ; Deroost K; Opdenakker G; Van den Steen PE Trends Parasitol; 2021 Mar; 37(3):226-239. PubMed ID: 33223096 [TBL] [Abstract][Full Text] [Related]
10. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328 [TBL] [Abstract][Full Text] [Related]
12. A perspective on malaria vaccines. Desowitz RS; Miller LH Bull World Health Organ; 1980; 58(6):897-908. PubMed ID: 6783333 [TBL] [Abstract][Full Text] [Related]
13. Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation. Lee MS; Igari Y; Tsukui T; Ishii KJ; Coban C Vaccine; 2016 Apr; 34(18):2055-61. PubMed ID: 26976665 [TBL] [Abstract][Full Text] [Related]
14. Malaria: immune evasion by parasites. Hisaeda H; Yasutomo K; Himeno K Int J Biochem Cell Biol; 2005 Apr; 37(4):700-6. PubMed ID: 15694829 [TBL] [Abstract][Full Text] [Related]
17. A case for whole-parasite malaria vaccines. Wykes M; Good MF Int J Parasitol; 2007 Jun; 37(7):705-12. PubMed ID: 17408673 [TBL] [Abstract][Full Text] [Related]
18. Mathematical model for optimal use of sulfadoxine-pyrimethamine as a temporary malaria vaccine. Dembele B; Friedman A; Yakubu AA Bull Math Biol; 2010 May; 72(4):914-30. PubMed ID: 19908101 [TBL] [Abstract][Full Text] [Related]
19. The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies. Alpers MP; al-Yaman F; Beck HP; Bhatia KK; Hii J; Lewis DJ; Paru R; Smith TA P N G Med J; 1992 Dec; 35(4):285-97. PubMed ID: 1341090 [TBL] [Abstract][Full Text] [Related]